Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uchida

Showing results (261-270 of 461) with videos related to

Pageof 47
Sort By:
Journal of Neuro-Oncology|March 8, 2011
Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cellsHiroyuki Uchida, Kazunori Arita, Shunji Yunoue, et al.
Plos One|June 20, 2020
Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)Kohei Kitagawa, Ryuhei So, Nobuyuki Nomura, et al.
Journal of Psychiatric Research|March 16, 2017
Frontal and temporal cortical functional recovery after electroconvulsive therapy for depression: A longitudinal functional near-infrared spectroscopy studyJinichi Hirano, Akihiro Takamiya, Bun Yamagata, et al.
FEMS Microbiology Letters|December 9, 2003
Purification and characterization of an aldehyde oxidase from Pseudomonas sp. KY 4690Hiroyuki Uchida, Daisaku Kondo, Ayako Yamashita, et al.
Human Psychopharmacology|June 10, 2008
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidoneTakefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, et al.
BMC Psychiatry|June 4, 2024
Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapyMasaki Nakano, Michitaka Funayama, Taketo Takata, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 27, 2025
Long-interval intracortical inhibition in individuals with autism spectrum disorders: A TMS-EEG study with source estimation analysesYu Mimura, Shinichiro Nakajima, Mayuko Takano, et al.
Schizophrenia Research|October 18, 2011
Treatment resistant schizophrenia and response to antipsychotics: a reviewTakefumi Suzuki, Gary Remington, Benoit H Mulsant, et al.
General Hospital Psychiatry|July 23, 2013
Oversight of constipation in inpatients with schizophrenia: a cross-sectional studyTeruki Koizumi, Hiroyuki Uchida, Takefumi Suzuki, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 21, 2017
Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD DataKazunari Yoshida, Rachel Roberts, Takefumi Suzuki, et al.
Pageof 47

Showing results (261-270 of 461) with videos related to

Sort By:
Pageof 47
Journal of Neuro-Oncology|March 8, 2011
Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cellsHiroyuki Uchida, Kazunori Arita, Shunji Yunoue, et al.
Plos One|June 20, 2020
Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)Kohei Kitagawa, Ryuhei So, Nobuyuki Nomura, et al.
Journal of Psychiatric Research|March 16, 2017
Frontal and temporal cortical functional recovery after electroconvulsive therapy for depression: A longitudinal functional near-infrared spectroscopy studyJinichi Hirano, Akihiro Takamiya, Bun Yamagata, et al.
FEMS Microbiology Letters|December 9, 2003
Purification and characterization of an aldehyde oxidase from Pseudomonas sp. KY 4690Hiroyuki Uchida, Daisaku Kondo, Ayako Yamashita, et al.
Human Psychopharmacology|June 10, 2008
Effectiveness of antipsychotic polypharmacy for patients with treatment refractory schizophrenia: an open-label trial of olanzapine plus risperidone for those who failed to respond to a sequential treatment with olanzapine, quetiapine and risperidoneTakefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, et al.
BMC Psychiatry|June 4, 2024
Caution for psychiatrists: malignant hyperthermia risks with the anesthetic agent succinylcholine (Suxamethonium) during electroconvulsive therapyMasaki Nakano, Michitaka Funayama, Taketo Takata, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 27, 2025
Long-interval intracortical inhibition in individuals with autism spectrum disorders: A TMS-EEG study with source estimation analysesYu Mimura, Shinichiro Nakajima, Mayuko Takano, et al.
Schizophrenia Research|October 18, 2011
Treatment resistant schizophrenia and response to antipsychotics: a reviewTakefumi Suzuki, Gary Remington, Benoit H Mulsant, et al.
General Hospital Psychiatry|July 23, 2013
Oversight of constipation in inpatients with schizophrenia: a cross-sectional studyTeruki Koizumi, Hiroyuki Uchida, Takefumi Suzuki, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|February 21, 2017
Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD DataKazunari Yoshida, Rachel Roberts, Takefumi Suzuki, et al.
Pageof 47